| [1] |
Hashimoto H,Ozeki Y,Sato M, et al.Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung[J]. Cancer, 2006, 106(7): 1595-1601.
|
| [2] |
Tanakal F,Wada H,Fukui Y, et al.Thymidylate synthase (TS) gene expression in primary lung cancer patients：a large-scale study in Japanese population[J]. Ann Oncol, 2011, 22(8): 1791-1797.
|
| [3] |
Zheng Z,Li X,Schell MJ, et al.Thymidylate synthase in situ protei expression and survival in stage I nonsmall-cell cancer[J]. Cancer.2008, 112(12): 2765-2773.
|
| [4] |
Ceppi P,Volante M,Saviozzi S, et al.Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase[J]. Cancer, 2006, 107(7): 1589-1596.
|
| [5] |
张同梅,鲁葆华,秦娜, 等. 非小细胞肺癌患者肿瘤组织胸苷酸合酶表达的意义[J/CD]. 中华诊断学电子杂志, 2015, 3(4): 274-278.
|
| [6] |
Paz-Ares L,de Marinis F,Dediu M, et al.Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT)：a double-blind, phase 3, randomised controlled trial[J]. Lancet Oncol, 2012, 13(3): 247-255.
|
| [7] |
Okamoto I,Yoshioka H,Morita S, et al.Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer：results of a west Japan oncology group study[J]. J Clin Oncol, 2010, 28(36): 5240-5246.
|
| [8] |
Takeda M,Okamoto I,Hirabayashi N, et al.Thymidylate synthase and dihyropyrimidine dehydrogenase expression levels are associated with response to S-1 plus carboplatin in advanced non-small cell lung cancer[J]. Lung Cancer, 2011, 73(1): 103-109.
|
| [9] |
Scagliotti GV,Parikh P,von Pawel J, et al.Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naïve patients with advanced stage non-small cell lung cancer[J]. J Clin Oncol, 2008, 26(21): 3543-3551.
|
| [10] |
Migoshi T,Kondo K,Toba H, et al.Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur＋Uracil) in patients with non-small cell lung cancer[J]. Anticancer Res, 2007, 27(4l): 2641-2648.
|
| [11] |
Chen CY,Chang YL,Shih JY, et al.Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma：The association with treatment efficacy of pemetrexed[J]. Lung Cancer, 2011, 74(1): 132-138.
|
| [12] |
杨民,王峻,樊卫飞, 等. TS基因表达与培美曲塞治疗老年晚期肺腺癌疗效关系的研究[J]. 临床肿瘤学杂志, 2012, 17(4): 317-320.
|
| [13] |
Nicolson MC,Fennell DA,Ferry D, et al. Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small cell lung cancer in a prospective blinded assessment phase II clinical trail[J]. J Thora Oncol, 2013, 8(7): 930-939.
|
| [14] |
李然,任韶韶,张海梅, 等. 胸苷酸合酶在非小细胞肺癌中的表达与培美曲塞疗效相关性研究[J]. 现代医药卫生, 2013, 29(15): 2266-2269.
|
| [15] |
Wang L,Wang R,Pan Y, et al.The pemetrexed-containing treatments in the non-small cell lung cancer, is-/low thymedylate synthase expression better than ＋/high thymedylate synthase expression：a meta-analysis[J]. BMC Cancer, 2014(14): 205.
|
| [16] |
Liu Y,Yin TJ,Zhou R, et al.Expression of thymedylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small cell lung cancer：a meta-analysis[J]. Cancer Chemother Pharmacol, 2013, 72(5): 1125-1132.
|
| [17] |
Kawabata S,Chiang CT,Tsurutani J, et al.Rapamycin downregulates thymedylate synthase and poteniates the activity of pemetrexed in non-smal cell lung cancer[J]. Oncotarget, 2014, 5(4): 1062-1070.
|